All articles by Chemistry World – Page 24

  • News

    Animal testing alternatives for China

    2011-05-04T11:45:00Z

    Chinese researchers are starting to investigate alternatives to animal testing in a bid to modernise and cut costs

  • Podcast

    May 2011

    2011-05-01T00:00:00Z

    Chemistry World Podcast -May 20111:16 - Battery turns entropy into electricity3:35 - Antibacterial clays kill with iron5:54 - Yi-Fang Chu from Kraft Foods explains the potential health benefits and pitfalls drinking coffee13:06 - Origin of life experiments revisited15:53 - Cleaning up nuclear storage ponds19:16 - Katherine Holt from University College ...

  • Opinion

    Flashback

    2011-04-28T10:03:08Z

    20 years ago in Chemistry in Britain

  • Opinion

    Letters: May 2011

    2011-04-28T09:59:00Z

    There are many ways of discovering truth. The scientific method is one of the best. It depends on the carrying out of repeatable experiments. Science cannot really deal with a unique event. So I am surprised that Philip Ball (Chemistry World, April 2011, p33) dismisses so easily the practicality of ...

  • Opinion

    Comment

    2011-04-28T09:04:10Z

    How will chemistry change our diets in the next 10 years?

  • News

    News in Brief

    2011-04-28T08:25:38Z

    Short items, May 2011

  • News

    In the papers

    2011-04-27T15:51:16Z

    Short items

  • News

    Note book: June 2011

    2011-04-27T15:50:00Z

    Scientists to market The European Research Council, the EU funding programme for cutting edge research, is to offer scientists that it already funds, the chance to apply for a grant of €150,000 (£132,300) to help them develop their ideas for the marketplace. If successful in their applications, the ...

  • Business

    Business roundup: May 2011

    2011-04-27T15:48:00Z

    Pharmaceutical US approval for AZ thyroid cancer drug The US Food and Drug Administration (FDA) has approved orphan drug vandetanib for the treatment of thyroid cancer. The drug candidate is owned by pharma major AstraZeneca. The approval refers to medullary thyroid cancer that cannot be removed by surgery or ...

  • News

    How antidepressants spur brain growth

    2011-04-12T14:45:00Z

    New insight into activity in the hippocampus could help researchers develop better drugs, researchers say

  • News

    Power sources get flexible

    2011-04-07T09:35:00Z

    A high energy density, non-toxic battery for malleable electrochemical applications

  • News

    'Green' products don't live up to label claims

    2011-04-01T14:40:00Z

    Products claiming to be 'plant-based' or 'naturally sourced' hide surprising amounts of petrochemical ingredients

  • Podcast

    April 2011

    2011-04-01T00:00:00Z

    Chemistry World Podcast - April 20111:13 -Molecules that walk, hop and jump4:44 -Diagnosing diseases with CDs7:00 -James Landers tells us how to streamline forensic DNA profiling with microfluidics14:30 -Sensitive TB diagnosis using sugar17:05 -Harvesting energy from soft drinks19:25 -Zhong Lin Wang on picking up good vibrations to harvest energy from ...

  • News

    Cheap and efficient artificial leaf debuted

    2011-03-31T13:35:00Z

    MIT researchers say they can make artificial leaves for less than $50 each

  • Opinion

    Flashback

    2011-03-30T10:23:22Z

    25 years ago in Chemistry in Britain

  • Opinion

    Letters: April 2011

    2011-03-30T10:23:00Z

    With regard to your piece on 60 years of innovation (Chemistry World, March 2011, p38). Can I put in a plea for recognition of the pioneering work carried out in the UK on liquid crystal displays (LCDs) in the years following 1970. Following some early work on displays in the ...

  • Opinion

    Comment

    2011-03-29T15:28:03Z

    Medicinal chemistry's quest for potent drug candidates has resulted in molecules that are too large and too lipophilic for their own good

  • Business

    Business roundup: April 2011

    2011-03-29T15:02:00Z

    Pharmaceutical Forest pays $1.2bn for Clinical Data US pharma company Forest Laboratories has agreed to buy Clinical Data for $30 (£19) per share in cash, equivalent to $1.2 billion, plus $6 per share payable if Viibryd (vilazodone) reaches commercial milestones. Forest intends to use existing cash to finance the deal. ...

  • News

    Microfluidics to diagnose sleeping sickness

    2011-03-22T10:40:00Z

    An understanding of the physics of particle sorting can help separate parasites from blood for clearer analysis

  • News

    Scientists in Slovakia campaign against diversion of funding

    2011-03-03T14:45:00Z

    Thousands of people in Slovakia sign a petition to stop €120 million of EU science money going awry